Skip to main content

Riabni multiple strengths Images

Generic Name: rituximab

This medication has been identified as Riabni multiple strengths. It is supplied by Amgen Inc.

Riabni is used in the treatment of Follicular Lymphoma; Granulomatosis with Polyangiitis; Chronic Lymphocytic Leukemia; Microscopic Polyangiitis; Non-Hodgkin's Lymphoma and belongs to the drug class CD20 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Riabni multiple strengths is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Riabni multiple strengths medicine

Riabni

Generic Name
rituximab
Strength
multiple strengths
Availability
Prescription only
Drug Class
CD20 monoclonal antibodies
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amgen Inc.
National Drug Code (NDC)
multiple

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.